Age | Mean (sd) | 56.5 (11.1) |
---|---|---|
Distance from PMH (km) | Median (range) [IQR] | 22.2 (0.6–1480.2) [12.7–42.7] |
Gender | Male:Female | 339:328 (50.8:49.2) |
Tumor site | Breast | 46 (6.9) |
 | GI colorectal | 172 (25.8) |
 | GI non-colorectal | 178 (26.7) |
 | Genitourinary | 36 (5.4) |
 | Gynaecologic | 74 (11.1) |
 | Head and neck | 23 (3.5) |
 | Lung | 57 (8.6) |
 | Sarcoma | 8 (1.2) |
 | Skin and melanoma | 11 (1.7) |
 | Unknown primary | 42 (6.3) |
 | Multiple sites* | 6 (0.9) |
 | Other** | 14 (2.1) |
Number of prior regimens | 0 | 68 (10.2) |
 | 1 | 210 (31.5) |
 | 2 | 186 (27.9) |
 | 3 | 116 (17.4) |
 | 4 | 52 (7.8) |
 | 5 | 24 (3.6) |
 | 6+ | 11 (1.7) |
PS | 0 | 211 (31.6) |
 | 1 | 318 (47.7) |
 | 2 | 87 (13.0) |
 | 3 | 49 (7.4) |
 | 4 | 2 (0.3) |
Entered on trial | Yes:No | 197:470 (29.5:70.5) |
Referring physician | PMH Oncologist | 328 (49.2) |
 | External Oncologist | 310 (46.5) |
 | Family Physician | 12 (1.8) |
 | Other Physician | 13 (2.0) |
 | Unknown | 4 (0.6) |